Status:
COMPLETED
Probiotics and Intestinal Microbiome in Preterm Infants
Lead Sponsor:
Belal Alshaikh
Conditions:
Microbial Colonization
Eligibility:
All Genders
23-29 years
Phase:
PHASE3
Brief Summary
The gut microbiome plays a significant role in balancing the inflammatory system in the immature gut. A breakdown in this balance with altered colonization of the microbiota in very low birth weight (...
Eligibility Criteria
Inclusion
- Infants born less than 29 weeks gestation and \<1000 g birth weight admitted to the Neonatal Intensive Care Unit (NICU) at Foothills Medical Centre in Calgary.
Exclusion
- Infants with major congenital anomalies, hypoxic-ischemic injury, NEC or bowel perforation before 72 hours of life.
Key Trial Info
Start Date :
October 26 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 26 2021
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT03422562
Start Date
October 26 2017
End Date
April 26 2021
Last Update
January 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Foothills Medical Centre
Calgary, Alberta, Canada, T2N2T9